The relatively inexpensive nature of liquid biopsy may allow for more frequent screening among individuals who are at risk of developing pancreatic cancer.
Ajay Goel, PhD, AGAF
Advertisement
Articles by Ajay Goel, PhD, AGAF
The pancreatic cancer field may not be far from seeing the use of non-invasive blood tests in pancreatic cancer, said Ajay Goel, PhD, AGAF.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice
2
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
3
177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC
4
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
5
